Fig. 2From: Real life results in using 5-ASA for maintaining mild to moderate UC patients in Japan, a multi-center study, OPTIMUM StudyNumber of Patients by Disease Stage at Enrollment and by Drug. a Daily dose of Pentasa® b Daily dose of Asacol® c Daily dose of Salazopyrin®Back to article page